XFOR
X4 Pharmaceuticals, Inc.
Set alert
3.35 USD -0.01 -0.30%
3.19 Day range 3.41
2.45 52-week range 4.67
- YTD
- -16.25%
- 1 year
- -16.04%
- Open
- 3.33
- Prev close
- 3.36
- Mkt cap
- 332.14M
- Vol
- 706.24K
- Avg vol
- 854.15K
- EPS
- 0.02
- P/E
- 167.50
- Div yield
- 0.00%
More statistics
- Low
- 3.19
- High
- 3.41
- Forward P/E
- -1.23
- Beta
- 0.39
- Short ratio
- 8.64
- Inst. own
- 67.66%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 0.50158
- 200-d avg
- 0.79766
- 1y target
- 3.05
1Y chart
Closing price and volume
Compare XFOR
Chart and line up XFOR against other symbols or a saved comparison set.
- XFOR X4 Pharmaceuticals, Inc.
3.35
-0.01 -0.30%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | XFOR | SPY | QQQ |
|---|---|---|---|
| Last price | 3.35 | 755.72 | 690.49 |
| Change | -0.01 | -13.64 | -24.85 |
| Change % | -0.297619% | -1.77% | -3.47% |
| Open | 3.33 | 761.38 | 697.13 |
| Day high | 3.41 | 761.46 | 698.63 |
| Day low | 3.19 | 750.36 | 683.45 |
| Previous close | 3.36 | 769.36 | 715.34 |
| Volume | 706.24K | 77.70M | 85.24M |
| Average volume | 854.15K | 41.22M | 34.57M |
| Market cap | 332.14M | 812.08B | 483.28B |
| P/E ratio | 167.50 | 23.99 | 26.44 |
| Earnings per share | 0.02 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 4.67 | 779.09 | 759.66 |
| 52-week low | 2.45 | 631.97 | 558.28 |
| 1-week return | +3.40% | -0.559233% | -1.97% |
| 1-month return | +15.52% | -0.906075% | -6.66% |
| 3-month return | -16.25% | +1.89% | +1.02% |
| 6-month return | -17.69% | +5.16% | +3.41% |
| Year-to-date return | -16.25% | +10.82% | +12.40% |
| 1-year return | -16.04% | +11.16% | +10.29% |
| 2-year return | -77.67% | +32.90% | +42.71% |
| 50-day moving average | 3.34 | 767.63 | 725.41 |
| 200-day moving average | 3.80 | 728.53 | 679.17 |
| Target price | 3.05 | — | — |
| Beta | 0.388 | 0.00 | 0.00 |
| Short ratio | 8.64 | — | — |
| Institutional ownership | 67.66% | — | — |